Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michele Simbolo

Showing results (51-60 of 89) with videos related to

Pageof 9
Sort By:
Scientific Reports|August 24, 2019
Immunoevolution of mouse pancreatic organoid isografts from preinvasive to metastatic diseaseDea Filippini, Sabrina D' Agosto, Pietro Delfino, et al.
Plos One|August 16, 2014
Reporting tumor molecular heterogeneity in histopathological diagnosisAndrea Mafficini, Eliana Amato, Matteo Fassan, et al.
Scientific Reports|May 10, 2018
Genetic alterations analysis in prognostic stratified groups identified TP53 and ARID1A as poor clinical performance markers in intrahepatic cholangiocarcinomaMichele Simbolo, Caterina Vicentini, Andrea Ruzzenente, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|November 26, 2013
High-throughput mutation profiling identifies novel molecular dysregulation in high-grade intraepithelial neoplasia and early gastric cancersMatteo Fassan, Michele Simbolo, Emilio Bria, et al.
Journal of Clinical Medicine|April 30, 2021
Myeloid and T-Cell Microenvironment Immune Features Identify Two Prognostic Sub-Groups in High-Grade Gastroenteropancreatic Neuroendocrine NeoplasmsGiovanni Centonze, Vincenzo Lagano, Giovanna Sabella, et al.
Cancer Discovery|October 9, 2015
A Cross-Species Analysis in Pancreatic Neuroendocrine Tumors Reveals Molecular Subtypes with Distinctive Clinical, Metastatic, Developmental, and Metabolic CharacteristicsAnguraj Sadanandam, Stephan Wullschleger, Costas A Lyssiotis, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 28, 2018
Metformin Enhances Cisplatin-Induced Apoptosis and Prevents Resistance to Cisplatin in Co-mutated KRAS/LKB1 NSCLCMassimo Moro, Elisa Caiola, Monica Ganzinelli, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 16, 2019
Gene Expression Profiling of Lung Atypical Carcinoids and Large Cell Neuroendocrine Carcinomas Identifies Three Transcriptomic Subtypes with Specific Genomic AlterationsMichele Simbolo, Stefano Barbi, Matteo Fassan, et al.
The American Journal of Surgical Pathology|July 1, 2024
Tubulocystic Carcinoma of Bile Ducts: A Distinct Type of Cholangiocarcinoma Associated With Adenofibroma-type LesionsFrancesca Masetto, Andrea Mafficini, Burcu Saka, et al.
Expert Opinion on Therapeutic Targets|December 7, 2021
Molecular characterization of extrahepatic cholangiocarcinoma: perihilar and distal tumors display divergent genomic and transcriptomic profilesMichele Simbolo, Samantha Bersani, Caterina Vicentini, et al.
Pageof 9

Showing results (51-60 of 89) with videos related to

Sort By:
Pageof 9
Scientific Reports|August 24, 2019
Immunoevolution of mouse pancreatic organoid isografts from preinvasive to metastatic diseaseDea Filippini, Sabrina D' Agosto, Pietro Delfino, et al.
Plos One|August 16, 2014
Reporting tumor molecular heterogeneity in histopathological diagnosisAndrea Mafficini, Eliana Amato, Matteo Fassan, et al.
Scientific Reports|May 10, 2018
Genetic alterations analysis in prognostic stratified groups identified TP53 and ARID1A as poor clinical performance markers in intrahepatic cholangiocarcinomaMichele Simbolo, Caterina Vicentini, Andrea Ruzzenente, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|November 26, 2013
High-throughput mutation profiling identifies novel molecular dysregulation in high-grade intraepithelial neoplasia and early gastric cancersMatteo Fassan, Michele Simbolo, Emilio Bria, et al.
Journal of Clinical Medicine|April 30, 2021
Myeloid and T-Cell Microenvironment Immune Features Identify Two Prognostic Sub-Groups in High-Grade Gastroenteropancreatic Neuroendocrine NeoplasmsGiovanni Centonze, Vincenzo Lagano, Giovanna Sabella, et al.
Cancer Discovery|October 9, 2015
A Cross-Species Analysis in Pancreatic Neuroendocrine Tumors Reveals Molecular Subtypes with Distinctive Clinical, Metastatic, Developmental, and Metabolic CharacteristicsAnguraj Sadanandam, Stephan Wullschleger, Costas A Lyssiotis, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 28, 2018
Metformin Enhances Cisplatin-Induced Apoptosis and Prevents Resistance to Cisplatin in Co-mutated KRAS/LKB1 NSCLCMassimo Moro, Elisa Caiola, Monica Ganzinelli, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 16, 2019
Gene Expression Profiling of Lung Atypical Carcinoids and Large Cell Neuroendocrine Carcinomas Identifies Three Transcriptomic Subtypes with Specific Genomic AlterationsMichele Simbolo, Stefano Barbi, Matteo Fassan, et al.
The American Journal of Surgical Pathology|July 1, 2024
Tubulocystic Carcinoma of Bile Ducts: A Distinct Type of Cholangiocarcinoma Associated With Adenofibroma-type LesionsFrancesca Masetto, Andrea Mafficini, Burcu Saka, et al.
Expert Opinion on Therapeutic Targets|December 7, 2021
Molecular characterization of extrahepatic cholangiocarcinoma: perihilar and distal tumors display divergent genomic and transcriptomic profilesMichele Simbolo, Samantha Bersani, Caterina Vicentini, et al.
Pageof 9